Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Immunotherapy and Immune Responses
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the immunobiology of dendritic cells, their role in antigen presentation, modulation of immunity, and their potential applications in cancer immunotherapy and vaccine development. The research covers topics such as dendritic cell subsets, tumor antigen presentation, immune tolerance, and the use of adjuvants to enhance immune responses.
137,106
Works
3,816,087
Citations
IDs:OpenAlex
How has Immunotherapy and Immune Responses's publication output changed over time?
ScholarIQpublication output · 1988–2019
Output grew100% over the shown period — from 1 works in 1988 to 2 in 2019.
1
1
1
1
1
2
2
1988200220042009201020172019
Who are the most-cited researchers behind Immunotherapy and Immune Responses?
ScholarIQtop researchers by citations
What are the most-cited papers on Immunotherapy and Immune Responses?
ScholarIQmost cited works
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott, Robert Weber, Jeffrey A. Sosman, John B.A.G. Haanen, René González, Caroline Robert, Dirk Schadendorf, Jessica C. Hassel, Wallace Akerley, Alfons J.M. van den Eertwegh, Jose Lutzky, Paul Lorigan, Julia Vaübel, Gerald P. Linette, David Hogg, Christian H. Ottensmeier, Célèste Lebbé, Christian Peschel, Ian Quirt, Joseph I. Clark, Jedd D. Wolchok, Jeffrey S. Weber, Jason Tian, Michael Yellin, Geoffrey Nichol, Axel Hoos, Walter J. Urba
New England Journal of Medicine. 201015,211 CitationsOPEN ACCESS
Cancer immunoediting: from immunosurveillance to tumor escape
Gavin P. Dunn, Allen T. Bruce, Hiroaki Ikeda, Lloyd J. Old, Robert D. Schreiber
Nature Immunology. 20025,309 Citations
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Oliver M. Grauer, Pieter Wesseling, Gosse J. Adema
Brain Pathology. 20094,019 CitationsOPEN ACCESS
Cancer immunotherapy: moving beyond current vaccines
Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo
Nature Medicine. 20042,968 CitationsOPEN ACCESS
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott, Zhuting Hu, Derin B. Keskin, Sachet A. Shukla, Jing Sun, David J. Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie‐Hurder, Lauren Peter, Christina Chen, Oriol Olive, Todd A. Carter, Shuqiang Li, David Lieb, Thomas Eisenhaure, Evisa Gjini, Jonathan Stevens, William J. Lane, Indu Javeri, Kaliappanadar Nellaiappan, Andres Μ. Salazar, Heather Daley, Michael S. Seaman, Elizabeth I. Buchbinder, Charles H. Yoon, Maegan Harden, Niall J. Lennon, Stacey Gabriel, Scott J. Rodig, Dan H. Barouch, Jon C. Aster, Gad Getz, Kai W. Wucherpfennig, Donna Neuberg, Jerome Ritz, Eric S. Lander, Edward F. Fritsch, Nir Hacohen, Catherine J. Wu
Nature. 20172,956 Citations
Where is Immunotherapy and Immune Responses research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Immunotherapy and Immune Responses is open access?
ScholarIQopen access share
44%OPEN ACCESS
Gold
0%
Green
44%
Hybrid
0%
Bronze
0%
Closed
56%
Who collaborates most closely around Immunotherapy and Immune Responses?
ScholarIQco-authorship network
United States
67%
France
17%
Germany
17%